Biotechnology Jobs

CureAge Therapeutics · London

Lead the computationally guided design of a lipid nanoparticle delivery platform, applying chemical and biophysical principles to optimise LNP composition and formulation. Use AI-enabled chemistry, cheminformatics, predictive models and molecular modelling to prioritise formulation components, working closely with the experimental team and founding team in a small start-up.

Alloy Therapeutics UK Ltd · Cambridge · £45,000 – £50,000 pa

Design and build large-scale synthetic gene loci and transgenic platforms for antibody discovery, using CRISPR/Cas9, RMCE and site-specific integrases. Hands-on molecular biology including PCR, NGS, plasmid construction and flow-cytometric immunophenotyping, within a small multidisciplinary team working from dry-lab design to wet-lab validation.

GSK · USA - Pennsylvania - Upper Providence · £174,750 – £291,250 pa

Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, accountable for at least one asset or disease area and its Global Epidemiology Plan. Designs and oversees complex observational studies using claims, EHR and registry data, advises clinical, safety and regulatory matrix teams, and manages external partnerships and scientific dissemination. Also mentors junior epidemiologists and represents the company with regulators and at international conferences.

GSK · Boston, United States · £174,750 – £320,375 pa

Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, designing and overseeing complex studies on disease burden, treatment patterns and safety. Partners across clinical development, safety, regulatory and health outcomes, manages external collaborations, and mentors junior scientists. Hybrid role requiring on-site presence at least two days per week.

Isomorphic Labs · Cambridge, United States

Lead DMPK strategy across drug discovery projects, designing screening cascades and mechanistic experiments while integrating DMPK, PD and toxicology data for dose and safety predictions. Work closely with AI/ML platform teams to optimise computational ADME models and author regulatory sections, in a hybrid Cambridge, MA role.

Isomorphic Labs · London

Lead formulation strategy for small molecules across drug discovery and preclinical development, designing technologies such as solid dispersions and co-crystals to improve solubility, stability and manufacturability. Work within an interdisciplinary team alongside AI/ML drug design platform groups, managing external CRO resources and authoring regulatory submissions.

Novartis · London

Leads end-to-end translational strategy for neurodegenerative and neuromuscular programs, bridging preclinical research to Phase 1–2 clinical development. Accountable for biomarker strategy, clinical endpoint selection and early-phase trial design, and serves as the Translational Medicine representative within global cross-functional project and clinical trial teams.

Ipsen · London

Leads one or more Early Development Asset Teams, owning integrated strategy from candidate nomination through first-in-human trials across preclinical, translational, clinical, regulatory and CMC workstreams. Serves as scientific champion for oncology assets, presenting data and investment recommendations to governance bodies and contributing to in-licensing due diligence.

Vertex Pharmaceuticals · London

Leads the development and execution of international regulatory strategy across European and Rest of World markets, from first-in-human through post-marketing. Represents Global Regulatory Affairs on core development teams, manages project plans and resources, and advises senior management. Also a people manager within the International GRA leadership team, driving process improvement and regulatory policy engagement.

Ipsen · London

Leads global operational delivery of early development oncology programs, managing Clinical Project Managers, Monitoring Leads and CTAs. Owns the clinical development plan, CRO and site selection strategy, budgets and timelines, and serves on Asset Teams. Requires deep first-in-human and Phase I oncology trial expertise.

Pfizer · New York, United States · US$176,600 – US$294,300 pa

Leads global evidence generation strategy for a rare disease therapy, overseeing HEOR studies such as network meta-analyses, economic models, and patient-reported outcomes. Partners with cross-functional teams and country affiliates to support reimbursement and market access, managing vendors and budgets. Requires deep HTA and health economics expertise within a matrix organization.

Pfizer · Europe - Any Pfizer Site · US$176,600 – US$294,300 pa

Leads global health economics and outcomes research for a rare disease asset, developing evidence generation strategy and HEOR studies such as network meta-analyses, economic models and patient-reported outcomes. Oversees launch deliverables including value dossiers and systematic literature reviews, working with cross-functional and country teams to support reimbursement and patient access.

CSL · Maidenhead

Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.

CSL · Opfikon, Switzerland

Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence, and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.

Recursion · Salt Lake City, United States · US$200,000 – US$220,500 pa

Lead a team of computational biologists in early discovery, acting as a player-coach who balances hands-on analysis with mentorship. Integrate phenomics, transcriptomics, genomics and proteomics data to nominate oncology and immunology targets, define validation criteria and precision medicine strategies, partnering with biologists, engineers and translational experts.

Moderna · Oxford

Provides scientific and hands-on leadership for immunogenicity and ligand binding assay bioanalysis supporting mRNA-LNP therapeutic programs, spanning assay development, validation, clinical sample testing and regulatory submissions. Ensures GcLP compliance and partners with cross-functional teams, with opportunities to work alongside data and AI-enabled analytical approaches.

Vertex Pharmaceuticals · London

Oversees cell and gene therapy Contract Manufacturing Organizations as the primary on-site point of contact, providing operational, quality and technical oversight of cGMP commercial supply. Acts as a Person-in-Plant and SME within the Virtual Plant Team, managing deviations, change controls, batch data and supplier governance, with up to 50% travel and shift coverage for critical process steps.